AMPHOTERICIN B — all Canadian products
7 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is AMPHOTERICIN B, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02241630 | AMBISOME | ASTELLAS PHARMA CANADA INC | Powder For Solution | Intravenous | AMPHOTERICIN B 50 MG | Marketed | |
| 02405032 | AMPHOTERICIN B FOR INJECTION, USP | STERIMAX INC | Powder For Solution | Intravenous | AMPHOTERICIN B 50 MG | Approved | |
| 00029149 | FUNGIZONE | CHEPLAPHARM ARZNEIMITTEL GMBH | Powder For Solution | Intravenous | AMPHOTERICIN B 50 MG | Marketed | |
| 02554186 | TARO-AMPHOTERICIN B LIPOSOMAL | TARO PHARMACEUTICALS INC | Powder For Solution | Intravenous | AMPHOTERICIN B 50 MG | Approved | |
| 02231590 | ABELCET | LEADIANT BIOSCIENCES, INC | Suspension | Intravenous | AMPHOTERICIN B 5 MG | Cancelled Post Market | |
| 02241749 | AMPHOTEC 100 MG | THREE RIVERS PHARMACEUTICALS LLC | Powder For Suspension | Intravenous | AMPHOTERICIN B 100 MG | Cancelled Post Market | |
| 02241750 | AMPHOTEC 50 MG | THREE RIVERS PHARMACEUTICALS LLC | Powder For Suspension | Intravenous | AMPHOTERICIN B 50 MG | Cancelled Post Market |
Browse other molecules: